Clinical Trials on SAH (Subarachnoid Hemorrhage) in Netherlands
Total 353 results
-
Travere Therapeutics, Inc.RecruitingFocal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | Minimal Change Disease | Alport Syndrome | IgA VasculitisUnited States, Italy, Netherlands, Poland, Spain, United Kingdom, Germany, Sweden
-
ECRI bvUniversity of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaboratorsCompletedCoronary Artery Disease | PCI | High Bleeding RiskNetherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedHemophilia AUnited States, Poland, United Kingdom, Netherlands, South Africa, Hong Kong, Australia, Ireland
-
CelgeneCompletedMultiple MyelomaAustria, Italy, France, Spain, Netherlands, Germany, Greece, United Kingdom
-
Swedish Orphan BiovitrumSyneos HealthActive, not recruitingHemophilia A, SevereGermany, Spain, France, Czechia, Netherlands, Ireland, Austria, Croatia, Greece, Italy, Norway, Slovenia, Sweden, United Kingdom
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNetherlands, Belgium, Germany, Spain, Czechia, Greece, Italy, Denmark, Serbia, Turkey
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Spain, Netherlands, United Kingdom, Bulgaria, Lithuania, Russian Federation, Switzerland, Ukraine
-
Baxalta now part of ShireActive, not recruitingHemophilia ASpain, Thailand, Hungary, Taiwan, Korea, Republic of, Czechia, Germany, Sweden, Italy, Croatia, United States, Bulgaria, Netherlands
-
Kartos Therapeutics, Inc.CompletedCancer | Glioblastoma | Multiple Myeloma | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, France, Netherlands
-
Novartis PharmaceuticalsCompletedBone Marrow Diseases | Hematologic Diseases | Blood Coagulation Disorders | Hemorrhagic Disorders | Primary Myelofibrosis | Myeloproliferative Disorders | Polycythemia Vera | Thrombocytosis | Essential Thrombocythemia | Blood Platelet DisordersUnited Kingdom, Belgium, Canada, France, Australia, Netherlands, Spain, Denmark, Ireland, Italy, Germany
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
TakedaBaxalta Innovations GmbH, now part of ShireCompletedVon Willebrand DiseaseUnited States, Spain, Italy, Turkey, Germany, Russian Federation, Netherlands, France, Canada
-
Lava TherapeuticsActive, not recruitingAcute Myeloid Leukemia | Multiple Myeloma | Chronic Lymphocytic LeukemiaUnited States, Spain, France, Netherlands
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Glanzmann's DiseaseSpain, Bulgaria, Pakistan, Belgium, Germany, France, United Kingdom, Italy, Hungary, Netherlands, United States, Algeria, Austria, Sweden, Switzerland
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedHemophilia AUnited States, Belgium, France, Norway, Netherlands, Austria, Hungary, Italy, Poland, Portugal, Romania, Russian Federation, Spain, Sweden
-
Swedish Orphan BiovitrumActive, not recruitingHemophilia ASpain, Germany, Czechia, Italy, Estonia, Finland, Greece, Netherlands, Saudi Arabia, Slovenia, Sweden, Switzerland, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedTransplantation | Lymphoma (Non-Hodgkin's Lymphoma) | Hodgkin's Disease or Multiple Myeloma | Front Line MobilizationNetherlands, France, Germany, Sweden, Spain, Italy, United Kingdom
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, United Kingdom, Netherlands, Australia, France
-
AstraZenecaCompletedAcute Myeloid Leukemia | Multiple Myeloma | Chronic Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | High Risk Myelodysplastic Syndrome | Small Lymphocytic Lymphoma | B-cell Non-Hodgkin Lymphoma | Richter's Syndrome | T-cell Non-Hodgkin Lymphoma | Relapsed or Refractory...United Kingdom, Germany, Netherlands
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple Myeloma | Previously Treated Amyloid Light-chain (AL) AmyloidosisBelgium, United States, United Kingdom, Spain, France, Netherlands
-
SanofiRecruitingThrombotic Thrombocytopenic PurpuraItaly, Belgium, France, Greece, United States, Austria, Canada, Czechia, Germany, Japan, Netherlands, Spain, United Kingdom
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
University Hospital, GenevaCompletedAfibrinogenemia, CongenitalFrance, Turkey, Switzerland, Netherlands, Spain, India, Poland, Canada, United States, Algeria, Egypt, Germany, Italy, Japan, Kuwait, Lebanon, Morocco, Pakistan, Serbia, Slovakia, Tunisia
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.RecruitingVon Willebrand Disease (VWD)United States, Italy, Spain, Netherlands, Turkey, France, Austria, Germany, Russian Federation
-
Fondazione Angelo Bianchi BonomiSintesi Research SrlActive, not recruitingType 3 Von Willebrand's DiseaseFinland, France, Germany, Hungary, Iran, Islamic Republic of, Italy, Netherlands, Spain, Sweden, United Kingdom
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, China, Israel, Netherlands, Spain, Japan
-
OctapharmaCompletedSevere Haemophilia AFrance, Japan, United States, Canada, Croatia, Finland, Netherlands, North Macedonia, Slovenia
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, Germany, Netherlands, Israel, Spain, Saudi Arabia, France
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Spain, United Kingdom, Taiwan, Malaysia, Bulgaria, Hong Kong, Korea, Republic of, Netherlands, Turkey, Ukraine
-
CSL BehringCompletedCongenital Hemophilia AUnited States, Austria, Germany, Malaysia, Netherlands, Philippines, Ukraine, Romania, Spain, Australia, France, Georgia, Italy, Lebanon, Poland, Portugal, Switzerland, Thailand, Turkey
-
Janssen-Cilag B.V.CompletedMultiple Myeloma | Hematological NeoplasmsNetherlands
-
Bioverativ, a Sanofi companyCompletedHemophilia ATurkey, Australia, Canada, France, Germany, Hungary, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
-
Ablynx, a Sanofi companyCompletedAcquired Thrombotic Thrombocytopenic PurpuraUnited States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Hungary, Israel, Italy, Netherlands, Spain, Switzerland, Turkey, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia APoland, Belgium, France, Italy, Spain, United States, Australia, Netherlands, New Zealand, Sweden, Germany, Finland, Hungary
-
Janssen Pharmaceutica N.V., BelgiumRecruitingRelapsed/Refractory Multiple MyelomaGermany, Italy, Belgium, Spain, Netherlands, France, United Kingdom
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseUnited States, Spain, Australia, Taiwan, Czechia, Turkey, Ukraine, Netherlands, Italy, United Kingdom, Austria, Germany, Russian Federation
-
Janssen-Cilag International NVCompletedMultiple MyelomaFrance, Poland, Belgium, Germany, Israel, Portugal, Turkey, Finland, Sweden, Netherlands, Norway
-
TakedaCompletedMultiple MyelomaUnited States, Netherlands, Czechia, France, Greece, Poland
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsSaudi Arabia, Algeria, Turkey, Germany, Poland, Netherlands, Italy, Belgium, South Africa, United Kingdom, Sweden, Austria, Portugal, France, Czech Republic, Venezuela
-
PedNet Haemophilia Research FoundationLund University HospitalRecruitingFactor IX Deficiency | Factor VIII DeficiencyNorway, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
Hoffmann-La RocheCompletedPrimary Myelofibrosis | Polycythemia Vera | Post-Essential Thrombocythemia MyelofibrosisUnited States, Netherlands, Italy, United Kingdom, Canada, France, Germany, Israel
-
Mundipharma Research LimitedActive, not recruitingMultiple Myeloma | Hodgkin's Lymphoma | Hematological Malignancies | Cutaneous T Cell LymphomaFrance, United States, Netherlands, Spain, Switzerland, Germany, Italy
-
Merck Sharp & Dohme LLCRecruitingEssential ThrombocythemiaPoland, Israel, Australia, Hong Kong, Japan, New Zealand, Taiwan, Korea, Republic of, United States, Spain, Italy, Netherlands, Germany, France, Sweden, Turkey
-
Bioverativ, a Sanofi companySwedish Orphan BiovitrumCompletedHemophilia BUnited States, Italy, Ireland, New Zealand, United Kingdom, Australia, Netherlands, Denmark, Poland, Sweden, France
-
Hoffmann-La RocheActive, not recruitingHemophilia A | Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor | Moderate Hereditary Factor VIII Deficiency Disease Without InhibitorUnited States, Netherlands, Belgium, France, Germany, South Africa, Spain, Canada, United Kingdom, Poland
-
BayerCompletedHemophilia ABelgium, New Zealand, Netherlands, Greece, United Kingdom, Austria, United States, Italy, Romania, Bulgaria, Canada, Israel, Poland, Lithuania, Norway, Argentina, Spain
-
Bioverativ, a Sanofi companyCompletedFactor VIII DeficiencyUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaUnited States, Turkey, Canada, Netherlands, Australia, Germany, France
-
CSL BehringActive, not recruitingHemophilia BUnited States, Belgium, Netherlands, Denmark, Germany, Ireland, Sweden, United Kingdom